The basic characteristics of the included studies. حسب Junyin Pan (20700411)

الموضوعات:

Common definitions and criteria for metabolic syndrome. حسب Junyin Pan (20700411)

الموضوعات:

Assessment of study bias in the included research. حسب Junyin Pan (20700411)

الموضوعات:

Summary of subgroup analysis results. حسب Junyin Pan (20700411)

الموضوعات:

Original study data. حسب Junyin Pan (20700411)

الموضوعات:

Results of the effect of dietary anthocyanins on health outcomes, including effect size and heterogeneity analysis. حسب Junyin Pan (20700411)

الموضوعات:

Forest plot. حسب Junyin Pan (20700411)

الموضوعات:

Risk of bias assessment for eligible randomized controlled trials. حسب Junyin Pan (20700411)

الموضوعات:

S2 File - حسب Junyin Pan (20700411)

الموضوعات:

Funnel plot. حسب Junyin Pan (20700411)

الموضوعات:

Summary of studies identified in the literature search, including studies excluded from the analysis and reasons for exclusion. حسب Junyin Pan (20700411)

الموضوعات:

The flow chart of study selection process. حسب Junyin Pan (20700411)

الموضوعات:

Data extracted from included studies for the systematic review and meta-analysis. حسب Junyin Pan (20700411)

الموضوعات:

Specifications and outcomes of clinical trial studies included in the meta-analysis. حسب Junyin Pan (20700411)

الموضوعات:

Bivariate analysis results. حسب Oejin Shin (20855617)

"…Employing multi-channel sequence analysis, we model various material hardship trajectories and examine their association with mental and physical health. …"

Sequence analysis results. حسب Oejin Shin (20855617)

"…Employing multi-channel sequence analysis, we model various material hardship trajectories and examine their association with mental and physical health. …"

Descriptive analysis. حسب Oejin Shin (20855617)

"…Employing multi-channel sequence analysis, we model various material hardship trajectories and examine their association with mental and physical health. …"

Comparing A) ROS and B) GSH levels in COCs versus DOs recovered from PMSG-stimulated NMRI mice cultured in absence or presence of 0.5 µM PA during IVM. Data are presented as means... حسب Shahrzad Ronasi (20933556)

Table2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.DOCX حسب Sofia Schaeffer (20379954)

"…Further, data from sleep questionnaires proved sleep-wake disruption in patients with MASLD. We objectively assessed sleep-wake rhythms in patients with biopsy-proven MASLD (n = 35) and healthy controls (HC, n = 16) using actigraphy 24/7 for 4 weeks. …"

Table1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.DOCX حسب Sofia Schaeffer (20379954)

"…Further, data from sleep questionnaires proved sleep-wake disruption in patients with MASLD. We objectively assessed sleep-wake rhythms in patients with biopsy-proven MASLD (n = 35) and healthy controls (HC, n = 16) using actigraphy 24/7 for 4 weeks. …"